STAAR Surgical (NASDAQ: STAA) is a global leader in implantable phakic intraocular lenses (ICLs), designed to reduce or eliminate the need for glasses or contacts. For over 30 years, STAAR has focused on developing and marketing its proprietary Implantable Collamer® Lenses, made from a biocompatible material proven to deliver long-term vision correction without removing corneal tissue. The EVO ICL™ product line offers visual freedom through a quick, minimally invasive procedure. STAAR has sold over 3 million ICLs in 75+ countries. Founded in 1982 and headquartered in Lake Forest, California, STAAR also operates R&D, manufacturing, and packaging facilities in California and Switzerland.
Learn more at www.EVOICL.com and www.staar.com.
